ThyCa To Award Two New Research Grants in 2010

In 2010, for the eighth year in a row, ThyCa: Thyroid Cancer Survivors' Association, Inc. will award new grants for thyroid cancer research.

ThyCa will award two new grants in 2010. Each grant will be for 2 years. One grant will support research on follicular-cell-derived thyroid cancer, including papillary, follicular, anaplastic, and variants. The other grant will support research on medullary thyroid cancer.

The ThyCa Research grants are open to all researchers and institutions worldwide.

An independent expert panel of the American Thyroid Association (ATA) will select the grant recipients. ATA is the professional association of clinicians and researchers concerned with thyroid diseases.

The Call for Proposals and eligibility requirements will be available on the ATA web site. The deadline for submission of a proposal summary to the ATA is January 31, 2010. The ATA Research Committee will rank proposals according to their scientific merit. ATA will notify the authors of selected proposals by early March and will invite them to submit complete grant applications.

"We are grateful all our generous donors and volunteers for making these grants possible," said ThyCa Executive Director Gary Bloom. “More thyroid cancer research is urgently needed, to better understand thyroid cancer and find cures for all thyroid cancer. We greatly appreciate the ATA’s support in our research grant process.”

The ThyCa grants, begun in 2003, are the first-ever thyroid cancer research grants to be funded entirely by thyroid cancer patients, caregivers, and friends.

ThyCa has awarded its grants to researchers at the following institutions:

• Cochin Institut, Paris, France
• Harvard Medical School, Boston, Massachusetts
• Johns Hopkins University School of Medicine, Baltimore, Maryland
• Ohio State University, Columbus, Ohio and Medical University of Gdansk, Poland
• Memorial Sloan-Kettering Cancer Center, New York, New York
• Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois
• University Hospital Basel, Basel, Switzerland
• University Hospital Duesseldorf, Duesseldorf, Germany
• University of California Los Angeles (UCLA)/Veterans Affairs West Los Angeles Health Care System, Los Angeles, California.
• University of Texas M.D. Anderson Cancer Center, Houston, Texas

ThyCa has two Research Funds. One fund supports research of follicular-cell-derived thyroid cancer, including papillary, follicular, anaplastic, and variants. The other research fund supports research of medullary thyroid cancer.

ThyCa invites everyone to join us in our quest to find a cure for all thyroid cancer.